Background The increasing prioritisation of healthcare quality across the six domains of
efficiency, safety, patient-centredness, effectiveness, timeliness and accessibility has given …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the
disease and depends on many factors. Grading of Recommendations Assessment …

In this review, we discuss recent publications on asthma and review the studies that have
reported on the different aspects of the prevalence, risk factors and prevention, mechanisms …

Background Allergen immunotherapy (AIT) is the only causal treatment for respiratory
allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …

Background The number of patients affected by allergies is increasing worldwide. The
resulting allergic diseases are leading to significant costs for health care and social systems …

Background Mobile health can be used to generate innovative insights into optimizing
treatment to improve allergic rhinitis (AR) control. Objectives A cross-sectional real-world …